Navigating the Debate on Managing Large (≥4 cm) Thyroid Nodules

Purpose. Discordant practice guidelines for managing large thyroid nodules may result in unnecessary surgeries and costs. Recent data suggest similar false-negative rates in fine needle aspiration (FNA) biopsies between small (<4 cm) and large (≥4 cm) nodules, indicating that monitoring rather th...

Full description

Saved in:
Bibliographic Details
Main Authors: Samantha N. Steinmetz-Wood, Amanda G. Kennedy, Bradley J. Tompkins, Matthew P. Gilbert
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2022/6246150
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850158762494525440
author Samantha N. Steinmetz-Wood
Amanda G. Kennedy
Bradley J. Tompkins
Matthew P. Gilbert
author_facet Samantha N. Steinmetz-Wood
Amanda G. Kennedy
Bradley J. Tompkins
Matthew P. Gilbert
author_sort Samantha N. Steinmetz-Wood
collection DOAJ
description Purpose. Discordant practice guidelines for managing large thyroid nodules may result in unnecessary surgeries and costs. Recent data suggest similar false-negative rates in fine needle aspiration (FNA) biopsies between small (<4 cm) and large (≥4 cm) nodules, indicating that monitoring rather than surgery may be appropriate for large biopsy-negative nodules. We investigated the management of thyroid nodules ≥4 cm to determine the proportion of surgeries not necessary for diagnostic purposes and examined for potential predictors. Methods. This was a retrospective cohort study of patients who received a FNA of nodule(s) ≥4 cm between 11/1/2014 and 10/31/2019 at the University of Vermont Medical Center. A surgery was considered unnecessary if the FNA result was benign in the absence of any of the following: compressive symptoms, family history of thyroid cancer in a first degree relative, history of neck irradiation, toxic nodule or toxic multinodular goiter, or substernal extension. Data were analyzed with Wilcoxon rank sum tests, chi square, or Fisher’s exact tests. Results. 177 patients had a ≥4 cm nodule during the timeframe and half (54.2%) had surgery. Patients who underwent surgery were significantly younger (51.5 years vs. 62 years; P<0.001), more likely to report obstructive symptoms (34.4% vs. 12.1%; P<0.001) and had a larger nodule size (5.0 cm vs. 4.7 cm; P=0.26). Forty-one patients with benign (Bethesda II) FNA results had surgery, all with negative surgical pathology. Thirteen percentage (23/177) of surgeries were potentially not necessary for diagnostic purposes. Conclusion. Approximately half of our patients with ≥4 cm nodules had surgery, with 13% having surgery not necessary for diagnostic purposes revealing opportunities for improving care and costs.
format Article
id doaj-art-65e1aec005bd4d9d921cb0c09da0e5bc
institution OA Journals
issn 1687-8345
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-65e1aec005bd4d9d921cb0c09da0e5bc2025-08-20T02:23:46ZengWileyInternational Journal of Endocrinology1687-83452022-01-01202210.1155/2022/6246150Navigating the Debate on Managing Large (≥4 cm) Thyroid NodulesSamantha N. Steinmetz-Wood0Amanda G. Kennedy1Bradley J. Tompkins2Matthew P. Gilbert3University of Vermont Medical CenterDepartment of Medicine Quality ProgramDepartment of Medicine Quality ProgramUniversity of Vermont Medical CenterPurpose. Discordant practice guidelines for managing large thyroid nodules may result in unnecessary surgeries and costs. Recent data suggest similar false-negative rates in fine needle aspiration (FNA) biopsies between small (<4 cm) and large (≥4 cm) nodules, indicating that monitoring rather than surgery may be appropriate for large biopsy-negative nodules. We investigated the management of thyroid nodules ≥4 cm to determine the proportion of surgeries not necessary for diagnostic purposes and examined for potential predictors. Methods. This was a retrospective cohort study of patients who received a FNA of nodule(s) ≥4 cm between 11/1/2014 and 10/31/2019 at the University of Vermont Medical Center. A surgery was considered unnecessary if the FNA result was benign in the absence of any of the following: compressive symptoms, family history of thyroid cancer in a first degree relative, history of neck irradiation, toxic nodule or toxic multinodular goiter, or substernal extension. Data were analyzed with Wilcoxon rank sum tests, chi square, or Fisher’s exact tests. Results. 177 patients had a ≥4 cm nodule during the timeframe and half (54.2%) had surgery. Patients who underwent surgery were significantly younger (51.5 years vs. 62 years; P<0.001), more likely to report obstructive symptoms (34.4% vs. 12.1%; P<0.001) and had a larger nodule size (5.0 cm vs. 4.7 cm; P=0.26). Forty-one patients with benign (Bethesda II) FNA results had surgery, all with negative surgical pathology. Thirteen percentage (23/177) of surgeries were potentially not necessary for diagnostic purposes. Conclusion. Approximately half of our patients with ≥4 cm nodules had surgery, with 13% having surgery not necessary for diagnostic purposes revealing opportunities for improving care and costs.http://dx.doi.org/10.1155/2022/6246150
spellingShingle Samantha N. Steinmetz-Wood
Amanda G. Kennedy
Bradley J. Tompkins
Matthew P. Gilbert
Navigating the Debate on Managing Large (≥4 cm) Thyroid Nodules
International Journal of Endocrinology
title Navigating the Debate on Managing Large (≥4 cm) Thyroid Nodules
title_full Navigating the Debate on Managing Large (≥4 cm) Thyroid Nodules
title_fullStr Navigating the Debate on Managing Large (≥4 cm) Thyroid Nodules
title_full_unstemmed Navigating the Debate on Managing Large (≥4 cm) Thyroid Nodules
title_short Navigating the Debate on Managing Large (≥4 cm) Thyroid Nodules
title_sort navigating the debate on managing large ≥4 cm thyroid nodules
url http://dx.doi.org/10.1155/2022/6246150
work_keys_str_mv AT samanthansteinmetzwood navigatingthedebateonmanaginglarge4cmthyroidnodules
AT amandagkennedy navigatingthedebateonmanaginglarge4cmthyroidnodules
AT bradleyjtompkins navigatingthedebateonmanaginglarge4cmthyroidnodules
AT matthewpgilbert navigatingthedebateonmanaginglarge4cmthyroidnodules